Understanding ethnic inequities associated with tobacco use in Aotearoa New Zealand: a quantitative analysis.


Journal

Health promotion international
ISSN: 1460-2245
Titre abrégé: Health Promot Int
Pays: England
ID NLM: 9008939

Informations de publication

Date de publication:
01 Jun 2024
Historique:
medline: 25 6 2024
pubmed: 25 6 2024
entrez: 25 6 2024
Statut: ppublish

Résumé

Despite the inclusion of both individual interventions and population-based measures in the Aotearoa New Zealand (Aotearoa NZ) Tobacco Control Programme, the gap between Māori, Pacific peoples and European/Asian/Other (EAO) populations in tobacco use has not decreased significantly. Tobacco control interventions that focus on individual behaviour change have produced little impact towards reducing tobacco smoking inequities for Māori and Pacific peoples in Aotearoa NZ. Using data from the New Zealand Health Survey (NZHS), this research investigates the impact of the wider determinants of health and individual-level factors on inequities in tobacco use between Māori, Pacific peoples and EAO. A conceptual framework was developed to support the theoretical positioning of this research and to inform data categorization, framing, discourse, analyses and interpretation. We conducted hierarchical regression to examine the effect of factors from each domain on ethnic inequities in tobacco use. We found that socioeconomic factors accounted for a significant amount of the disparity in adults currently smoking between Māori and Pacific peoples and EAO. Our results suggest that socioeconomic factors may be a more effective target of intervention than individual behaviours for reducing tobacco-related inequities. Addressing the broader determinants of health through comprehensive cross-agency cooperation to reduce ethnic inequities in tobacco use in Aotearoa NZ is likely to be more effective than individual behaviour change approaches.

Identifiants

pubmed: 38916147
pii: 7698204
doi: 10.1093/heapro/daae060
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Te Hiringa Hauora/Health Promotion Agency

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Niveditha Gurram (N)

Insights and Evaluation, Health Promotion Directorate, National Public Health Service, Te Whatu Ora-Health New Zealand, Level 16, 101 The Terrace, Wellington 6011, New Zealand.

Felix Carroll (F)

Insights and Evaluation, Health Promotion Directorate, National Public Health Service, Te Whatu Ora-Health New Zealand, Level 16, 101 The Terrace, Wellington 6011, New Zealand.

Christine Ngā Hau Elers (CNH)

Insights and Evaluation, Health Promotion Directorate, National Public Health Service, Te Whatu Ora-Health New Zealand, Level 16, 101 The Terrace, Wellington 6011, New Zealand.

Ririwai Fox (R)

Insights and Evaluation, Health Promotion Directorate, National Public Health Service, Te Whatu Ora-Health New Zealand, Level 16, 101 The Terrace, Wellington 6011, New Zealand.

Sara Tepaeru Minster (ST)

Insights and Evaluation, Health Promotion Directorate, National Public Health Service, Te Whatu Ora-Health New Zealand, Level 16, 101 The Terrace, Wellington 6011, New Zealand.

Erena Wikaire (E)

Insights and Evaluation, Health Promotion Directorate, National Public Health Service, Te Whatu Ora-Health New Zealand, Level 16, 101 The Terrace, Wellington 6011, New Zealand.

Lynsey Brown (L)

Insights and Evaluation, Health Promotion Directorate, National Public Health Service, Te Whatu Ora-Health New Zealand, Level 16, 101 The Terrace, Wellington 6011, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH